EVENTS DURING THE FOURTH QUARTEREuropean Patent Office granted Active Biotech's patent application for eye drop formulation of laquinimod (October 23)Active Biotech's clinical trial of tasquinimod in ...

RLF-TD011 has previously received orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for the treatment of EB. The Company also intends to seek qualified infectious disease ...

Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration's (FDA) Orange Book upon the product's approval - DEER PARK, Ill., Feb. 07, 2025 (GLOBE ...

In the world of luxury fashion, few trademarks are as iconic and instantly recognizable as the red soles of Christian ...

Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...

Enveric Biosciences said its lead candidate for treating mental-health disorders was a big step closer toward winning patent protection. The Cambridge, Mass., biotechnology company on Thursday ...

SALT LAKE CITY (AP) — The U.S. Patent and Trademark Office has refused a request by the NHL’s Utah Hockey Club to trademark the name Utah Yetis. The USPTO issued a refusal Jan. 9, citing the ...

Coke Morgan Stewart was sworn in as the Commerce Department’s deputy undersecretary for intellectual property and the deputy director of the US Patent and Trademark Office on Monday shortly after ...

Microsoft’s Office has been an iconic product, with billions relying on it to accomplish their work. However, in 2022, the brand made a surprising decision to rebrand itself. Microsoft Office ...

EU Takes China to WTO Over High-Tech Patent Royalties BRUSSELS (Reuters) -The European Commission filed a complaint at the World Trade Organization on Monday against what it said was China's ...

The Commission said the case was connected to another dispute the EU brought to the WTO in 2022 related to Chinese anti-suit injunctions, which limit telecom patent holders' ability to enforce IP ...